The board overhaul introduces execution risk despite strong incoming director credentials. Watch for the Q1 2026 10-Q (due May 2026) for full financials and any strategic pivot under new leadership. The non-independent Chairman nomination is unusual and may raise governance concerns with institutional investors.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 1 $0.9890entry
- T+1 · 7mo ago +10.21%α +10.55% · $1.09
- T+5 · 6mo ago +11.22%α +8.88% · $1.10
- T+20 · 6mo ago −9.00%α −14.28% · $0.9000
- T+60 · 4mo ago −32.24%α −35.31% · $0.6701
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
TELA Bio reported preliminary Q1 2026 revenue of ~$19.0M, slightly above the $18.5M consensus, but the filing is dominated by a near-total board overhaul: Chairman Doug Evans and three other directors are resigning, replaced by four new directors including a non-independent Chairman nominee. The board refresh, while bringing experienced MedTech executives, introduces uncertainty about strategic direction and governance stability.
Key Financial Metrics
Key Facts
- Preliminary Q1 2026 revenue of ~$19.0M, vs $18.5M consensus and prior Q1 guidance of ~$18.5M
- Chairman Doug Evans and three other directors (Kurt Azarbarzin, Vince Burgess, Federica O'Brien) resigning effective after 2026 Annual Meeting
- Joseph Capper (CEO of MiMedx) nominated as Class I director and proposed as Chairman, not expected to qualify as independent
- Three new directors appointed: Guido Neels (EW Healthcare), Guy Nohra (Alta Partners), Paul Thomas (Prominex CEO), all deemed independent
- Board refresh follows prior Q4 2025 earnings beat (EPS -$0.17 vs -$0.19 consensus) and 18% YoY revenue growth
- Company guided 2026 revenue growth of at least 8% in March 2026 earnings call
Financial Impact
Preliminary Q1 2026 revenue ~$19.0M, ~2.7% above $18.5M consensus; no EPS or profitability data provided
Risk Factors
- Board instability and governance concerns with non-independent Chairman
- Preliminary revenue is unaudited and subject to revision
- Company remains unprofitable with $38.8M net loss in FY2025 and $55.7M in long-term debt
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-053102 |
| Document: 0001104659-26-053102-index-headers.html | 0001104659-26-053102 |
| Document: 0001104659-26-053102-index.html | 0001104659-26-053102 |
| Document: 0001104659-26-053102.txt | 0001104659-26-053102 |
| 8-K Data (Synthetic) | 0001104659-26-053102 |
Track record
20 reports on TELA
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +18.61% at T+5 after the Aug 10, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $0.7610 Now $0.7620 +0.13% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.8200 Now $0.7620 −7.07% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.8201 Now $0.7620 −7.08% settles Nov 23
- Nov 10, 20266d ago S-3 Bearish 5/10 Entry $0.9418 Now $0.7620 +19.09% settles Nov 18
- Nov 10, 20266d ago Press Release Bearish 5/10 Entry $0.9418 Now $0.7620 +19.09% settles Nov 18
- Oct 27, 202620d ago Press Release Neutral 2/10 Entry $0.9760 to $0.8378 Now $0.7620 −21.93% ▼ −14.16% −13.45% vs SPY
- Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.07 to $1.10 Now $0.7620 −28.79% ▲ +2.34% +3.32% vs SPY
- Oct 5, 20266w ago 8-K Bullish 5/10 Entry $1.14 to $1.08 Now $0.7620 −33.16% ▼ −5.26% −5.69% vs SPY
- Aug 31, 202611w ago 8-K Mixed 6/10 Entry $0.7380 to $0.8301 Now $0.7620 +3.25% ▲ +12.48% +12.62% vs SPY
- Aug 10, 202614w ago 8-K Bearish 7/10 Entry $0.7900 to $0.6430 Now $0.7620 +3.54% ▲ +18.61% +18.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers